Sufficient scientific evidence exists to recommend HPV DNA testing in the triage of women with equivocal cytology and in follow-up after the treatment of precursor lesions. However, due to a low ...

However, the sensitivity of the Pap smear is low and so testing for DNA of the causal agent of cervical cancer, human papillomavirus (HPV), either as an alternative or in conjunction with a Pap ...

PDS Biotechnology (PDSB) announced the publication of circulating tumor DNA results for its lead immunotherapy candidate, Versamune HPV, in Clinical Cancer Research, a journal of the American ...

today announced the publication of circulating tumor DNA (ctDNA) results for its lead immunotherapy candidate, Versamune® HPV, in Clinical Cancer Research, a journal of the American Association ...

today announced the publication of circulating tumor DNA (ctDNA) results for its lead immunotherapy candidate, Versamune ® HPV, in Clinical Cancer Research, a journal of the American Association for ...